Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Douglas McNeel
University of Wisconsin Madison, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Madison Vaccines Inc
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research. The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Modulating the Inflammasome to Generate Robust Cell Mediated Immunity
The goal of cancer immunotherapy is the generation of tumor specific cell mediated immunity that results in the killing of tumor cells while leaving healthy neighboring cells intact. Attenuated strains of Listeria monocytogenes that express tumor antigens have shown great promise as immunotherapeutic platforms. The goal of this proposal is to understand the mechanism by which L. monocytogenes triggers immunity and to generate strains that induce more robust responses through the modulation of the innate immune response to the bacterium.
Filed on May 15, 2015.
Tell us what you know about Douglas McNeel's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Douglas McNeel”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Douglas McNeel | University of Wisconsin Madison | Conflict of Interest | Madison Vaccines Inc | $0 - $4,999 |
Douglas McNeel | University of Wisconsin Madison | Conflict of Interest | Madison Vaccines Inc | $20,000 - $39,999 |
Douglas McNeel | University of Wisconsin Madison | Conflict of Interest | Madison Vaccines Inc | $450,000 - $499,999 |
Douglas McNeel | University of Wisconsin Madison | Conflict of Interest | Madison Vaccines Inc | $0 - $4,999 |
Douglas McNeel | Rbhs Cancer Institute of New Jersey | Conflict of Interest | Madison Vaccines Inc. | $0 - $4,999 |
Douglas McNeel | University of Wisconsin Madison | Conflict of Interest | Madison Vaccines Inc | $5,000 - $9,999 |
Douglas McNeel | Rbhs Cancer Institute of New Jersey | Conflict of Interest | Madison Vaccines Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.